BRIEF published on 08/28/2024 at 13:05, 2 months 23 days ago Starrex International Announces Inability To File Q2 Financials on Time Cease Trade Order Starrex International Q2 Financials Litigation Impact Stock Halt
PRESS RELEASE published on 08/28/2024 at 13:00, 2 months 23 days ago Starrex International Announces Inability To File Q2 Financials on Time Starrex International, Ltd. announces delay in filing financial statements, anticipates cease trade order due to litigation impact. Company provides contact information and advises on stock status Financial Statements Cease Trade Order Litigation Starrex International Stock Status
BRIEF published on 08/06/2024 at 13:20, 3 months 14 days ago Starrex International Announces Appointment of Independent Director Independent Director Board Appointment Starrex International David Lowe Business Experience
PRESS RELEASE published on 08/06/2024 at 13:15, 3 months 14 days ago Starrex International Announces Appointment of Independent Director Starrex International, Ltd. appoints David Lowe as independent Canadian director with extensive business experience and public company background. The Board welcomes his valuable input Board Of Directors Starrex International David Lowe Business Experience Public Company
PRESS RELEASE published on 02/06/2024 at 13:15, 9 months 14 days ago Starrex International Announces Resignation of President Starrex International, Ltd. announces resignation of President & CEO, appointment of Charles Burns as interim CEO, and commitment to expansion in the United States Title industry Interim CEO Expansion Resignation Starrex International United States Title Industry
PRESS RELEASE published on 12/15/2023 at 15:45, 11 months 5 days ago Starrex International Reaches Settlement on Outstanding Credit Facility
PRESS RELEASE published on 12/11/2023 at 15:05, 11 months 9 days ago Starrex International Faces Summary Judgement Application on Demand for Repayment of Credit Facility
PRESS RELEASE published on 10/18/2023 at 16:00, 1 year 1 month ago Starrex International Announces Demand for Repayment of Credit Facility
PRESS RELEASE published on 05/02/2023 at 03:20, 1 year 6 months ago Starrex International Announces Non-Binding Letter of Intent To Acquire the Magnolia Group of Companies
PRESS RELEASE published on 03/20/2023 at 18:45, 1 year 8 months ago Starrex International Announces Acquisition of All American Title Group of Companies
Published on 11/21/2024 at 10:03, 47 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 50 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 50 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 15 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 25 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 20 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 45 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 48 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 50 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 50 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 30 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo